In Brief: Eugenol for toothache
This article was originally published in The Tan Sheet
Executive Summary
Eugenol for toothache: OTC "feedback" meeting between FDA and representatives of The Mentholatum Company is scheduled for Sept. 8 to discuss the revised protocol for a study submitted by the firm in February for the efficacy of eugenol in toothache pain resulting from an open cavity ("The Tan Sheet" March 3, In Brief). The ingredient, contained in Mentholatum's Red Cross Toothache First Aid Medication, was classified as Category III (data are insufficient) in the 1991 tentative final monograph for oral discomfort products. The meeting will start at 1:30 p.m. in Suite 200 at FDA's 9201 Corporate Blvd. building, Rockville, Md...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning